Syndax Announces Participation at the Citi 2024 Global Healthcare Conference
Press Releases
Syndax Pharmaceuticals, Inc.  
November 27, 2024

Syndax Announces Participation at the Citi 2024 Global Healthcare Conference

WALTHAM, Mass., Nov. 27, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief

logo salamanca press

Salamanca Press

Local & Social